RLMD
RELMADA THERAPEUTICS, INC.
Company overview
- Market capitalization
- $404.28M
- Employees
- 17
- Latest publication
- 2026-09-29
About RELMADA THERAPEUTICS, INC.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 8,087,845USD | 8,072,479USD | 4,036,267USD | 2,819,377USD | 11,951,023USD | 10,999,981USD | 11,149,000USD | 14,752,061USD |
| Selling General Administrative | 11,373,909USD | 12,260,633USD | 6,291,079USD | 7,401,929USD | 6,267,412USD | 8,075,573USD | 11,860,000USD | 12,077,259USD |
| Total Operating Expenses | 19,461,754USD | 20,333,112USD | 10,327,346USD | 10,221,306USD | 18,218,435USD | 19,075,554USD | 23,009,000USD | 26,829,320USD |
| Operating Income | -19,461,754USD | -20,333,112USD | -10,327,346USD | -10,221,306USD | -18,218,435USD | -19,075,554USD | -23,009,000USD | -26,829,320USD |
| Interest Income | 959,762USD | 387,231USD | 247,013USD | 321,458USD | 440,287USD | 654,642USD | 856,478USD | 1,259,226USD |
| Net Interest Income | 959,762USD | 387,231USD | 247,013USD | 321,458USD | 440,287USD | 654,642USD | 856,478USD | 1,259,226USD |
| Income Before Tax | -19,051,956USD | -19,867,760USD | -10,091,496USD | -9,866,442USD | -17,559,465USD | -18,657,136USD | -21,726,000USD | -25,165,158USD |
| Net Income | -19,051,956USD | -19,867,760USD | -10,091,496USD | -9,866,442USD | -17,559,465USD | -18,657,136USD | -21,726,000USD | -25,165,158USD |
| Net Income From Continuing Ops | -19,051,956USD | -19,867,760USD | -10,091,496USD | -9,866,442USD | -17,559,465USD | -18,657,136USD | -21,725,970USD | -25,165,158USD |
| Ebitda | -19,051,956USD | -19,867,760USD | -10,091,496USD | -9,866,442USD | -17,559,465USD | 418,418USD | 1,282,000USD | 1,664,162USD |
| Total Other Income Expense Net | 409,798USD | 465,352USD | 235,850USD | 354,864USD | 658,970USD | 418,418USD | 1,283,000USD | 1,664,162USD |
| Ebit | — | — | — | — | — | -18,657,136USD | -21,726,000USD | -25,165,158USD |
| Depreciation And Amortization | — | — | — | — | — | 19,075,554USD | 23,008,000USD | 26,829,320USD |
| Income Tax Expense | — | — | — | — | — | — | — | -26,829USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — | — | 7,941USD |
| Research Development | 744,560USD | 46,175,512USD | 54,807,000USD | 90,621,570USD | 1,293,000USD | 7,872,397USD | — |
| Selling General Administrative | 311,904USD | 37,715,524USD | 48,895,000USD | 35,081,922USD | 5,925,335USD | 9,226,883USD | 9,090USD |
| Unclassified Operating Expenses | 58,043,736USD | — | — | — | — | — | — |
| Total Operating Expenses | 59,100,200USD | 83,891,036USD | 103,702,000USD | 125,703,492USD | 7,219,000USD | 17,099,280USD | 14,194USD |
| Operating Income | -59,100,200USD | -83,891,036USD | -103,702,000USD | -125,703,492USD | -7,219,000USD | -17,099,280USD | -12,052USD |
| Interest Income | 1,395,989USD | 3,530,021USD | 5,151,704USD | 1,199,077USD | — | — | — |
| Net Interest Income | 1,395,989USD | 3,530,021USD | 5,151,704USD | 1,199,077USD | — | — | — |
| Income Before Tax | -57,385,163USD | -79,979,354USD | -98,792,000USD | -125,751,809USD | -6,287,000USD | -20,803,596USD | -12,052USD |
| Net Income | -57,385,163USD | -79,979,354USD | -98,792,000USD | -125,751,809USD | -6,287,000USD | -20,803,596USD | -12,052USD |
| Net Income From Continuing Ops | -57,385,163USD | -79,979,354USD | -98,791,746USD | -125,751,809USD | — | — | — |
| Ebitda | -57,385,163USD | -79,979,354USD | 4,910,000USD | -125,750,551USD | -6,923,000USD | -20,789,418USD | -11,675USD |
| Total Other Income Expense Net | 1,715,037USD | 3,911,682USD | 4,910,000USD | -48,317USD | 932,312USD | -3,704,316USD | -377USD |
| Ebit | — | -79,979,000USD | -98,792,000USD | -125,751,809USD | -7,008,271USD | -20,798,674USD | -12,429USD |
| Depreciation And Amortization | — | 83,891,000USD | 103,702,000USD | 1,258USD | 85,271USD | 9,256USD | 754USD |
| Income Tax Expense | — | — | -103,702USD | 48,317USD | -716,000USD | — | -377USD |
| Cost Of Revenue | — | — | — | 1,258USD | 85,271USD | — | 5,799USD |
| Gross Profit | — | — | — | -1,258USD | -85,271USD | — | 2,142USD |
| Interest Expense | — | — | — | 48,317USD | 550USD | 4,922USD | — |
| Reconciled Depreciation | — | — | — | 1,258USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -125,751,809USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | 211,018USD | — | 4,727USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 235,362,794USD | 94,003,471USD | 14,876,244USD | 21,116,144USD | 27,679,417USD | 45,817,818USD | 55,724,505USD | 71,028,476USD |
| Other Current Assets | 1,380,151USD | 977,721USD | 967,745USD | 474,628USD | 596,410USD | 886,461USD | 1,584,803USD | 537,522USD |
| Total Liab | 16,630,217USD | 7,491,458USD | 5,410,705USD | 5,166,663USD | 5,238,926USD | 10,295,857USD | 8,099,323USD | 9,536,848USD |
| Total Stockholder Equity | 218,732,577USD | 86,512,013USD | 9,465,539USD | 15,949,481USD | 22,440,491USD | 35,521,961USD | 47,625,182USD | 61,491,628USD |
| Other Current Liab | 7,160,233USD | 4,861,583USD | 3,736,496USD | 3,772,636USD | 3,966,411USD | 6,160,827USD | 5,741,220USD | 5,362,280USD |
| Common Stock | 104,890USD | 73,333USD | 33,191USD | 33,191USD | 33,191USD | 30,174USD | 30,174USD | 30,174USD |
| Capital Stock | 104,890USD | 73,333USD | 33,191USD | 33,191USD | 33,191USD | 30,174USD | 30,174USD | 30,174USD |
| Retained Earnings | -717,319,154USD | -698,267,198USD | -678,399,438USD | -668,307,942USD | -658,441,500USD | -640,882,035USD | -622,224,899USD | -600,498,929USD |
| Cash | 9,776,400USD | 3,496,540USD | 1,384,484USD | 1,353,351USD | 1,149,706USD | 3,857,026USD | 1,483,789USD | 2,086,260USD |
| Cash And Short Term Investments | 233,963,143USD | 93,006,250USD | 13,886,524USD | 20,619,541USD | 27,061,032USD | 44,909,382USD | 54,117,727USD | 70,437,329USD |
| Total Current Assets | 235,343,294USD | 93,983,971USD | 14,854,269USD | 21,094,169USD | 27,657,442USD | 45,795,843USD | 55,702,530USD | 70,974,851USD |
| Total Current Liabilities | 12,891,634USD | 6,430,527USD | 5,189,598USD | 5,134,547USD | 5,231,421USD | 10,291,390USD | 8,086,761USD | 9,536,848USD |
| Net Debt | -9,776,400USD | -3,496,540USD | -1,384,484USD | -1,353,351USD | -1,149,706USD | -3,857,026USD | -1,483,789USD | -2,086,260USD |
| Short Term Investments | 224,186,743USD | 89,509,710USD | 12,502,040USD | 19,266,190USD | 25,911,326USD | 41,052,356USD | 52,633,938USD | 68,351,069USD |
| Accounts Payable | 5,731,401USD | 1,568,944USD | 1,453,102USD | 1,361,911USD | 1,265,010USD | 4,130,563USD | 2,345,541USD | 4,174,568USD |
| Common Stock Shares Outstanding | 86,596,873shares | 68,255,441shares | 33,191,622shares | 33,191,622shares | 30,409,000shares | 30,174,000shares | 30,174,000shares | 30,174,000shares |
| Non Current Assets Total | 19,500USD | 19,500USD | 21,974USD | 21,975USD | 21,975USD | 21,975USD | 21,975USD | 53,625USD |
| Non Current Liabilities Total | 3,738,583USD | 1,060,931USD | 221,106USD | 32,116USD | 7,505USD | 4,467USD | 12,562USD | 0USD |
| Non Currrent Assets Other | 19,500USD | 19,500USD | 21,974USD | 21,975USD | 21,975USD | 21,975USD | 21,975USD | 53,625USD |
| Net Working Capital | 222,451,660USD | 87,553,444USD | 9,664,671USD | 15,959,622USD | 22,426,021USD | 35,504,453USD | 47,615,769USD | 61,438,003USD |
| Unclassified Non Current Liabilities | 3,738,583USD | 1,060,931USD | — | — | — | — | — | — |
| Unclassified Equity | 935,841,951USD | 784,632,545USD | 687,798,595USD | 684,191,041USD | 680,815,609USD | 676,343,648USD | 669,789,733USD | 661,930,209USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 12,562USD | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 94,003,471USD | 45,817,818USD | 97,552,042USD | 152,905,179USD | 223,325,811USD | 118,186,204USD | 117,136,000USD | 3,048,079USD |
| Other Current Assets | 977,721USD | 886,461USD | 1,185,057USD | 4,035,186USD | 11,301,535USD | 903,190USD | 423,909USD | 426,921USD |
| Total Liab | 7,491,458USD | 10,295,857USD | 12,194,800USD | 12,468,877USD | 15,060,925USD | 12,603,458USD | 1,457,846USD | 8,561,155USD |
| Total Stockholder Equity | 86,512,013USD | 35,521,961USD | 85,357,242USD | 140,436,302USD | 208,264,886USD | 105,582,746USD | 115,678,000USD | -5,513,076USD |
| Other Current Liab | 4,861,583USD | 6,160,827USD | 8,688,791USD | 7,206,941USD | 3,868,423USD | 4,256,983USD | 824,936USD | 4,854,089USD |
| Common Stock | 73,333USD | 30,174USD | 30,099USD | 30,099USD | 27,740USD | 16,333USD | 14,457USD | 3,137USD |
| Capital Stock | 73,333USD | 30,174USD | 30,099USD | 30,099USD | 27,740USD | 16,333USD | — | 38,978USD |
| Retained Earnings | -698,267,198USD | -640,882,035USD | -560,902,681USD | -462,110,935USD | -305,067,112USD | -179,315,303USD | -119,858,000USD | -94,344,307USD |
| Cash | 3,496,540USD | 3,857,026USD | 4,091,568USD | 5,395,905USD | 44,443,439USD | 2,495,397USD | 36,278,519USD | 2,238,943USD |
| Cash And Short Term Investments | 93,006,250USD | 44,909,382USD | 96,323,860USD | 148,322,686USD | 211,909,606USD | 117,090,922USD | 116,443,000USD | 2,238,943USD |
| Total Current Assets | 93,983,971USD | 45,795,843USD | 97,508,917USD | 152,870,304USD | 223,297,518USD | 118,073,569USD | 116,940,000USD | 2,737,967USD |
| Total Current Liabilities | 6,430,527USD | 10,291,390USD | 12,194,800USD | 12,468,877USD | 15,060,925USD | 12,603,458USD | 1,457,846USD | 5,904,698USD |
| Net Debt | -3,496,540USD | -3,857,026USD | -4,091,568USD | -5,395,905USD | -44,443,439USD | -2,495,397USD | -36,168,272USD | 702,684USD |
| Short Term Investments | 89,509,710USD | 41,052,356USD | 92,232,292USD | 142,926,781USD | 167,466,167USD | 114,595,525USD | 80,164,823USD | — |
| Accounts Payable | 1,568,944USD | 4,130,563USD | 3,506,009USD | 5,261,936USD | 11,192,502USD | 8,346,475USD | 522,663USD | 765,439USD |
| Common Stock Shares Outstanding | 39,479,694shares | 30,164,000shares | 30,099,000shares | 29,629,000shares | 17,552,738shares | 15,594,000shares | 9,229,000shares | 3,136,000shares |
| Non Current Assets Total | 19,500USD | 21,975USD | 43,125USD | 34,875USD | 28,293USD | 112,635USD | 196,000USD | 310,112USD |
| Non Current Liabilities Total | 1,060,931USD | 4,467USD | 0USD | 123USD | 75USD | 542USD | 1,288,563USD | 2,656,457USD |
| Non Currrent Assets Other | 19,500USD | 21,975USD | 43,125USD | 34,875USD | 28,293USD | 111,377USD | 190,990USD | 24,788USD |
| Net Working Capital | 87,553,444USD | 35,504,453USD | 85,314,117USD | 140,401,427USD | 208,236,593USD | 105,470,111USD | — | 7,377,963USD |
| Unclassified Non Current Liabilities | 1,060,931USD | — | — | — | — | — | 1,288,563USD | 2,656,457USD |
| Unclassified Equity | 784,632,545USD | 676,343,648USD | 646,199,725USD | 602,487,039USD | 513,276,518USD | 284,865,383USD | 235,521,543USD | 88,789,116USD |
| Other Assets | — | — | — | 34,875USD | 28,293USD | 111,377USD | 190,834USD | 228,142USD |
| Net Receivables | — | — | — | 512,432USD | 86,377USD | 79,457USD | 73,091USD | 72,103USD |
| Inventory | — | — | — | 4,035,200USD | 11,301,500USD | 903,200USD | 459,000USD | 426,900USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | 0USD | 0USD | 0USD |
| Net Tangible Assets | — | — | — | 140,436,302USD | 208,264,886USD | 105,582,746USD | 115,678,294USD | 7,613,315USD |
| Unclassified Current Assets | — | — | — | -4,035,200USD | -11,301,500USD | — | — | — |
| Property Plant Equipment Net | — | — | — | — | 0USD | 1,258USD | 5,010USD | 12,080USD |
| Property Plant Equipment Gross | — | — | — | — | 16,700USD | 1,258USD | 5,000USD | 7,210USD |
| Current Deferred Revenue | — | — | — | — | — | — | 1,317,900USD | 659,500USD |
| Short Term Debt | — | — | — | — | — | — | 110,247USD | 285,170USD |
| Short Long Term Debt Total | — | — | — | — | — | — | 110,247USD | 2,941,627USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -1,317,900USD | -1,023,704USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 364,204USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -19,051,956USD | -19,867,760USD | -10,091,496USD | -9,866,442USD | -17,559,465USD | -18,657,136USD | -21,725,970USD | -17,768,122USD |
| Stock Based Compensation | 3,633,838USD | 3,211,003USD | 3,607,554USD | 3,473,064USD | 4,481,033USD | 6,718,307USD | 7,961,687USD | 7,213,419USD |
| Other Non Cash Items | 549,964USD | 827,105USD | -4,955,274USD | -33,407USD | -218,683USD | 236,224USD | -426,390USD | -87,649USD |
| Change In Working Capital | -199,334USD | 1,233,429USD | 4,717,360USD | 24,909USD | -4,769,918USD | 2,902,971USD | -2,465,718USD | -2,620,673USD |
| Total Cash From Operating Activities | -15,067,488USD | -14,596,223USD | -6,721,856USD | -6,401,876USD | -18,067,033USD | -8,799,634USD | -16,656,391USD | -13,263,025USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -4USD | -3USD | -4USD | 0USD | -5USD |
| Free Cash Flow | -15,067,490USD | -14,596,223USD | -6,721,855USD | -6,401,876USD | -18,067,033USD | -8,799,634USD | -16,656,391USD | -13,263,025USD |
| Investments | -135,226,997USD | -76,929,550USD | 6,752,989USD | 6,678,542USD | 15,359,713USD | 11,345,358USD | 16,143,521USD | 14,014,267USD |
| Total Cashflows From Investing Activities | -135,226,997USD | -76,929,550USD | 6,752,989USD | 6,678,542USD | 15,359,713USD | 11,345,358USD | 16,143,521USD | 14,014,267USD |
| Total Cash From Financing Activities | 156,574,345USD | 93,637,829USD | 0USD | -73,021USD | 0USD | -172,487USD | -89,601USD | 0USD |
| Issuance Of Capital Stock | 159,999,996USD | 93,637,829USD | — | — | 0USD | 0USD | 0USD | — |
| Change In Cash | 6,279,860USD | 2,112,056USD | 31,133USD | 203,645USD | -2,707,320USD | 2,373,237USD | -602,471USD | 751,242USD |
| Begin Period Cash Flow | 3,496,540USD | 1,384,484USD | 1,353,351USD | 1,149,706USD | 3,857,026USD | 1,483,789USD | 2,086,260USD | 1,335,018USD |
| End Period Cash Flow | 9,776,400USD | 3,496,540USD | 1,384,484USD | 1,353,351USD | 1,149,706USD | 3,857,026USD | 1,483,789USD | 2,086,260USD |
| Other Cashflows From Financing Activities | -65,651USD | — | — | -73,021USD | — | -172,487USD | -89,601USD | 14,014,267USD |
| Unclassified Financing Cash Flow | -3,360,000USD | — | — | — | — | — | — | -14,014,267USD |
| Other Cashflows From Investing Activities | — | -48,138,305USD | — | — | — | — | — | 14,014USD |
| Unclassified Investing Cash Flow | — | 48,138,305USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -57,385,163USD | -79,979,354USD | -98,791,746USD | -157,043,823USD | -125,751,809USD | -59,456,394USD | -15,005USD | -8,960,852USD |
| Stock Based Compensation | 14,961,645USD | 30,188,881USD | 43,811,149USD | 44,194,765USD | 40,494,476USD | 20,777,272USD | 2,761USD | 518,000USD |
| Other Non Cash Items | 586,178USD | -381,661USD | 241,157USD | -1,545,829USD | 1,247,394USD | 16,946USD | 173USD | 1,029,183USD |
| Change In Working Capital | -3,949,648USD | -1,583,664USD | 3,080,234USD | 10,593,270USD | -7,864,714USD | 10,849,623USD | -26USD | 700,064USD |
| Total Cash From Operating Activities | -45,786,988USD | -51,755,798USD | -51,659,206USD | -103,801,617USD | -91,873,395USD | -27,808,801USD | -12,092USD | -6,002,078USD |
| Capital Expenditures | 0USD | 0USD | -4USD | -3USD | -5USD | 0USD | 0USD | -12,391USD |
| Free Cash Flow | -45,786,990USD | -51,755,798USD | -51,659,210USD | -103,801,617USD | -91,873,395USD | -27,808,801USD | -12,092USD | -6,014,469USD |
| Investments | -48,138,306USD | 51,561,597USD | 50,453,332USD | 19,733,609USD | -54,118,036USD | -34,447,648USD | -80,164,823USD | -80,164,823USD |
| Total Cashflows From Investing Activities | -48,138,306USD | 51,561,597USD | 50,453,332USD | 19,733,609USD | -54,118,036USD | -34,447,648USD | -80,164USD | -12,391USD |
| Total Cash From Financing Activities | 93,564,808USD | -40,341USD | -98,463USD | 45,020,474USD | 187,939,473USD | 28,473,327USD | 126,109USD | 6,542,900USD |
| Issuance Of Capital Stock | 93,637,829USD | 246,747USD | 0USD | 43,432,319USD | 185,311,412USD | 20,527,158USD | — | 17,760,635USD |
| Change In Cash | -360,486USD | -234,542USD | -1,304,338USD | -39,047,534USD | 41,948,042USD | -33,783,122USD | 6,977USD | 528,431USD |
| Begin Period Cash Flow | 3,857,026USD | 4,091,568USD | 5,395,905USD | 44,443,439USD | 2,495,397USD | 36,278,519USD | 2,238USD | 1,710,512USD |
| End Period Cash Flow | 3,496,540USD | 3,857,026USD | 4,091,567USD | 5,395,905USD | 44,443,439USD | 2,495,397USD | 9,216USD | 2,238,943USD |
| Other Cashflows From Financing Activities | -73,021USD | -287,088USD | -98,463USD | 2,291,875USD | 2,628,061USD | 8,056,416USD | 126,109USD | -12,391USD |
| Other Cashflows From Investing Activities | — | 51,561,597USD | — | 19,733USD | -54,118USD | -34,448USD | -80,164USD | — |
| Unclassified Investing Cash Flow | — | -51,561,597USD | — | — | — | — | 80,164,823USD | 80,164,823USD |
| Change To Account Receivables | — | — | 512,432USD | -426,055USD | 79,457USD | 73,091USD | -169,363USD | 224,980USD |
| Depreciation | — | — | — | 0USD | 1,258USD | 3,752USD | 4USD | 2,627USD |
| Change To Inventory | — | — | — | 426,055USD | -79,457USD | — | 169,363USD | — |
| Change To Liabilities | — | — | — | 3,759,558USD | 2,846,027USD | 7,823,812USD | 163,772USD | 1,340,190USD |
| Net Borrowings | — | — | — | -50,000USD | 0USD | -110,247USD | -368,695USD | -285,170USD |
| Sale Purchase Of Stock | — | — | — | 42,728,599USD | — | — | 113,894,520USD | 17,760,635USD |
| Cash And Cash Equivalents Changes | — | — | — | -39,047,534USD | — | — | — | 6,977,611USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | -113,525,825USD | -10,920,174USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.